Login / Signup
Jean Paul Atallah
ORCID
Publication Activity (10 Years)
Years Active: 2017-2022
Publications (10 Years): 2
Top Topics
Metastatic Breast Cancer
Clinical Trial
Phase Iii
Prognostic Factors
Top Venues
Journal of oncology
Expert opinion on investigational drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bader Alshamsan
,
Ahmed Mostafa Gad
,
Maaz Kamal Alata
,
Mashari Alzahrani
,
Tusneem Elhassan
,
Jean Paul Atallah
Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Journal of oncology
2022 (2022)
Sassine Ghanem
,
Gautam Krichore Valecha
,
Sami Hossri
,
Uroosa Ibrahim
,
Jean Paul Atallah
Investigational PD-1 inhibitors for advanced non-small lung cancer: new players in a shifting paradigm.
Expert opinion on investigational drugs
26 (12) (2017)